Advertisement · 728 × 90
#
Hashtag
#acc2025
Advertisement · 728 × 90
Preview
Who is Carson Beck Girlfriend? All about Hanna Cavinder Why did Carson Beck leave Georgia? The Miami quarterback reveals his transfer reasons, NIL deal, injury update, girlfriend details, age, and career stats in 2025.

Who is Carson Beck Girlfriend? All about Hanna Cavinder
#CarsonBeck #MiamiFootball #GeorgiaBulldogs #CollegeFootball #NILDeals #Quarterback #CFBPlayoff #MiamiHurricanes #FootballNews #ACC2025
gtvnewshd.com/uncategorize...

0 0 0 0

Woooooo! Day 2 of #ACC2025 #AtlantaComicConvention!

#convention #comicconvention #comic #comicart #art #merch #fantasyart #fantasy #artist #artistalley #fanart

3 2 0 0
Post image

All set up at #AtlantaComicConvention #ACC2025!

#comic #convention #arristalley #vendor #merch #fanart #fantasyart #comic #comicart #pokemon

6 2 0 0
Preview
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference From nurse-led care models and intensive blood pressure management to the emergence of novel lipid-lowering agents; discover the highlights in CVD prevention presented at the 2025 American College of…

From nurse-led care models and intensive blood pressure management to the emergence of novel lipid-lowering agents; discover the highlights in #CVD prevention presented at the #ACC2025 Conference.

👉 buff.ly/MOgT0gW

#CardioSky #MedSky

0 1 0 0
Students receiving poster prizes.

Students receiving poster prizes.

Thanks to @rscadvances.rsc.org for their generous sponsorship of #ACC2025

2 1 0 0
Post image Post image Post image

Just a few pictures from last night's cruise down the Chao Phraya river. #acc2025

4 0 0 0
Post image

Are you an early career researcher heading to ACC 2025? Join us on July 8 for an evening social event organized by the NextCom team—don’t miss it! (You can RSVP at: tinyurl.com/acc25-nextco...)

#ACC2025 #OpenSource #EarlyCareerResearchers

3 0 1 0

🌐 For the first time, #ACC2025 recordings feature quality-controlled Spanish & Portuguese subtitles—making expert insights more accessible worldwide.

Was this helpful?
📝 Take 1 minute to share your feedback: bit.ly/44GfYY9

#AMR #Antibiotics #GlobalHealth #GARDP

1 0 0 0
Preview
Antimicrobial Chemotherapy Conference 2025 Day 1 Introductory remarks Mike Allen, Regional Medical Advisor (Antibiotics), MSD UK & BSAC General Secretary Session 1 - Keynote presentation

🎥 The #ACC2025 recording is now available!

From resistance trends to PK/PD and clinical challenges, watch the full conference to catch key insights for researchers, clinicians, and AMR specialists.

▶️ Start watching: revive.gardp.org/antimicrobia...

1 0 0 1
Post image Post image Post image Post image

a great day on saturday at Austria Comic Con Wels 🔥😍

#AccWels #AustriaComicConWels #AccWels2025 #Acc2025 #Acc

9 1 0 0
cardiologie

cardiologie

Retrouver l’actualité du congrès américain de cardiologie #ACC2025 sur notre page dédiée : études phares dans l’insuffisance cardiaque et la maladie coronaire, sotatercept dans l’HTAP, sémaglutide contre la MAP...
http://ms.spr.ly/63329SKxiW

0 0 0 0
Preview
Survival Improves for Heart Attacks During Marathons Better emergency action plans implemented by race organizers are keeping more runners who experience a heart attack alive, new research shows.

Despite rising participation the rate of heart attacks during marathons has remained steady - and far more people are surviving them thanks to improved CPR training and access to defibrillators. My story for @medscape.com #cardiosky #acc2025
www.medscape.com/viewarticle/...

27 7 1 1
Preview
ACC : focus sur les maladies coronaires Michel Zeitouni commente 4 études présentées à l’ACC 2025 : WARRIOR, RIVAWAR, ALLEPRE et SMART-CHOICE-3.

Maladies coronaires : le Dr Michel Zeitouni, cardiologue interventionnel, commente 4 études présentées au congrès de l'American College of Cardiology (#ACC2025) : WARRIOR, RIVAWAR, ALLEPRE et SMART-CHOICE-3.
http://ms.spr.ly/63326SyK5E

0 0 0 0
Preview
Insuffisance cardiaque : de nouvelles données en faveur d’un traitement de la carence en fer Selon une méta-analyse, les patients souffrant d'insuffisance cardiaque et de carence en fer traités avec du fer intraveineux présentent des taux plus faibles de décès cardiovasculaire ou d'hospitalisation pour insuffisance cardiaque.

Insuffisance cardiaque : de nouvelles données en faveur d’un traitement de la carence en fer
#ACC2025
http://ms.spr.ly/63321q7WRJ

0 0 0 0
Preview
ACC : les études clés dans l’insuffisance cardiaque  Les résultats marquants des essais Dapa TAVI, FAIR-HF2 et autres études clés présentées au congrès de cardiologie ACC 2025. Des messages pratiques pour optimiser le traitement des insuffisants cardiaques, de la prévention post-TAVI à la supplémentation en fer. Avec A. Bennis et W. Amara

Les études clés de l'#ACC2025 dans l’insuffisance cardiaque
Le point sur Dapa TAVI, FAIR-HF2, Altshock2, FRESH-UP et coordination infirmières avec Walide Amara et Ahmed Bennis
http://ms.spr.ly/63321q0fSB

1 0 0 0
Preview
STRIDE: Semaglutide Shows It Has Legs in Peripheral Artery Disease Plus, oral version of GLP-1 drug boasts cardiovascular efficacy in SOUL

"We haven't had a new therapy for function in PAD in 25 years." -- Marc Bonaca, MD, MPH, of @cumedicalschool.bsky.social, discussing new trial data showing that #semaglutide (Ozempic) improved walking ability in #diabetic patients with lower limb PAD. #ACC2025
www.medpagetoday.com/meetingcover...

0 0 1 0
Post image

Congratulations!!!!
#PAs do THAT
#ACC2025
#AAPA

0 0 0 0
Preview
AI identifies women at higher risk of MACE An AI tool designed for coronary CT angiography can identify women at high risk for major adverse cardiovascular events (MACE).

AI analysis of CCTA exams can identify women at higher risk of major adverse cardiovascular events, according to a study presented at #ACC2025. 👇
buff.ly/itUfEHV

#radiology #cardiology #medicalimaging #ImagingAI

1 4 1 0
Post image Post image Post image Post image

Congratulations to @anumminhas @theresaboyer
for wining JACC authorship awards for work in Maternal CV Health 👏🏼👏🏼👏🏼
@erinmichos.bsky.social
@hopkinsheart.bsky.social
@accintouch.bsky.social @janetcatov #acc2025

10 3 0 2

Lilly's ANGPTL3 drug solbinsiran shows broad lipid impact $LLY #ACC2025 firstwordpharma.com/story/5946325

0 0 0 0

AstraZeneca's oral PCSK9 inhibitor halves cholesterol levels $AZN #ACC2025 firstwordpharma.com/story/5946110

0 0 0 0

Merck & Co.'s Winrevair reduces mortality in most severe PAH patients $MRK #ACC2025 firstwordpharma.com/story/5946052

0 0 0 0
Post image

On the docket this morning at #ACC2025

CKD subgroup in the SUMMIT HF trial and I'm intrigued by what will be discussed. @hswapnil.medsky.social

1 0 0 0

Lilly's investigational siRNA cuts lipoprotein(a) levels by over 90% $LLY #ACC2025 firstwordpharma.com/story/5945990

0 0 0 0
Post image

Meeting up with friends at Dearly Beloved in River North @sandeepnathan #ACC2025 @bhavadharani.bsky.social @purviparwani.bsky.social

2 1 0 0
Middle-aged man walking on a sunny suburban street with a semi-transparent anatomical overlay of the heart and glowing blood vessels on his chest, symbolizing improved cardiovascular health. The man appears active and comfortable, reflecting the benefits of treatment. Image is AI-generated for illustration purposes.

Middle-aged man walking on a sunny suburban street with a semi-transparent anatomical overlay of the heart and glowing blood vessels on his chest, symbolizing improved cardiovascular health. The man appears active and comfortable, reflecting the benefits of treatment. Image is AI-generated for illustration purposes.

Rybelsus® (oral semaglutide 14 mg) demonstrated a 14% reduction in major adverse cardiovascular events (MACE) in adults with type 2 diabetes and cardiovascular or chronic kidney disease.

jcst2d.com/index.php?vi...

#Rybelsus #Type2Diabetes #CardiovascularHealth #SOULTrial #ACC2025

1 0 0 0
Post image

Oral semaglutide demonstrates CV benefits and reduces MACE in people with #T2D on top of standard of care, including use of SGLT-2 inhibitors in the SOUL trial www.ahajournals.org/doi/10.1161/... #ACC2025

3 1 0 0
Preview
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes | NEJM The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ca...

The SOUL CVOT with oral semaglutide #T2D 14% reduction in MACE. The mean follow-up was 47.5 months; NNT over 3 yrs=50;2.95 kg placebo-subtracted #weightloss 26.9% baseline use of SGLT2i #CVD #ACC2025 www.nejm.org/doi/full/10....

5 4 1 1
Middle-aged woman walking confidently on a sunny suburban street, with a semi-transparent overlay showing healthy femoral arteries in her legs, symbolizing improved circulation and mobility. AI-generated for illustration purposes.

Middle-aged woman walking confidently on a sunny suburban street, with a semi-transparent overlay showing healthy femoral arteries in her legs, symbolizing improved circulation and mobility. AI-generated for illustration purposes.

​A new study presented at ACC 2025 reveals that Ozempic can improve walking distance and quality of life in individuals with type 2 diabetes and peripheral artery disease (PAD).

jcst2d.com/index.php?vi...

#Ozempic #Type2Diabetes #PeripheralArteryDisease #STRIDETrial #ACC2025

0 0 0 0